Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.61 |
| ▸ | RARB | P10826 | 9/20 | 0.61 |
| ▸ | RARG | P13631 | 8/20 | 0.61 |
| ▸ | RXRG | P48443 | 12/20 | 0.58 |
| ▸ | RXRB | P28702 | 11/20 | 0.58 |
| ▸ | RARA | P10276 | 5/20 | 0.58 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6915917 | 1.00 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL6915924 | 1.00 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL7178687 | 1.00 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL6915920 | 1.00 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL6916842 | 0.90 | RXRA (0.49) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL4146810 | 0.90 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL14020532 | 0.90 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL4146808 | 0.90 | RXRA (0.61) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL7735872 | 0.75 | RXRA (0.52) | RXRARARBRARGRXRGRXRB | |
| SCHEMBL7735871 | 0.75 | RXRA (0.52) | RXRARARBRARGRXRGRXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040019072-A1 | Dimer-selective RXR modulators and methods for their use | CANAN-KOCH STACIE (US) | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019072-A1 | Dimer-selective RXR modulators and methods for their use | RXRG, RXRB, RXRA | RXRA 3/4885RARB 27/4885RARG 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.